• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2:病毒学、流行病学、免疫学与疫苗研发

SARS-CoV-2: Virology, epidemiology, immunology and vaccine development.

作者信息

Baay Marc, Lina Bruno, Fontanet Arnaud, Marchant Arnaud, Saville Melanie, Sabot Philippe, Duclos Philippe, Vandeputte Joris, Neels Pieter

机构信息

P95 Epidemiology & Pharmacovigilance, Leuven, Belgium.

University Claude Bernard Lyon, VirPath Research Laboratory, Lyon, France.

出版信息

Biologicals. 2020 Jul;66:35-40. doi: 10.1016/j.biologicals.2020.06.005. Epub 2020 Jun 23.

DOI:10.1016/j.biologicals.2020.06.005
PMID:32600951
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7309765/
Abstract

This first International Alliance for Biological Standardization Covid-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-income countries, to discuss the virology, epidemiology and immunology of, and the vaccine development for SARS-CoV-2.

摘要

首届国际生物标准化联盟新冠病毒网络研讨会汇聚了众多国际利益相关者,包括学术界、监管机构、资助者和行业代表,还有来自低收入和中等收入国家的相当规模的代表团,共同探讨严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的病毒学、流行病学、免疫学以及疫苗研发情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e922/7309765/09cfdd25427a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e922/7309765/09cfdd25427a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e922/7309765/09cfdd25427a/gr1_lrg.jpg

相似文献

1
SARS-CoV-2: Virology, epidemiology, immunology and vaccine development.严重急性呼吸综合征冠状病毒2:病毒学、流行病学、免疫学与疫苗研发
Biologicals. 2020 Jul;66:35-40. doi: 10.1016/j.biologicals.2020.06.005. Epub 2020 Jun 23.
2
Keeping track of the SARS-CoV-2 vaccine pipeline. 跟踪 SARS-CoV-2 疫苗研发管线。
Nat Rev Immunol. 2020 Nov;20(11):650. doi: 10.1038/s41577-020-00455-1.
3
SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)人类感染对照模型:伦理、挑战病原体生产及监管问题
Biologicals. 2020 Sep;67:69-74. doi: 10.1016/j.biologicals.2020.08.006. Epub 2020 Aug 15.
4
Reporting COVID-19: A Conversation with Jon Cohen of Science.报道新冠疫情:与《科学》杂志的乔恩·科恩对话
Am J Trop Med Hyg. 2020 Oct;103(4):1744-1747. doi: 10.4269/ajtmh.20-1034.
5
COVID-19 vaccine trials: Duty of care and standard of prevention considerations.2019冠状病毒病疫苗试验:注意义务与预防标准考量
Vaccine. 2020 Nov 10;38(48):7578-7580. doi: 10.1016/j.vaccine.2020.10.012. Epub 2020 Oct 9.
6
The false promise of herd immunity for COVID-19.新冠病毒群体免疫的虚假承诺。
Nature. 2020 Nov;587(7832):26-28. doi: 10.1038/d41586-020-02948-4.
7
Advances in skin science enable the development of a COVID-19 vaccine.皮肤科学的进展推动了新冠疫苗的研发。
J Am Acad Dermatol. 2020 Oct;83(4):1226-1227. doi: 10.1016/j.jaad.2020.05.126. Epub 2020 May 30.
8
All eyes on a hurdle race for a SARS-CoV-2 vaccine.所有人的目光都聚焦在新冠病毒疫苗的一场障碍赛上。
Nature. 2020 Oct;586(7830):501-502. doi: 10.1038/d41586-020-02926-w.
9
Coronavirus vaccines get a biotech boost.冠状病毒疫苗获得生物技术助力。
Nature. 2020 Jul;583(7817):647-649. doi: 10.1038/d41586-020-02154-2.
10
The Race to Develop a COVID-19 Vaccine.新冠疫苗研发竞赛。
Am J Nurs. 2020 Oct;120(10):14-15. doi: 10.1097/01.NAJ.0000718556.85319.00.

引用本文的文献

1
Peculiar weather patterns effects on air pollution and COVID-19 spread in Tokyo metropolis.特殊天气模式对东京大都市区空气污染和 COVID-19 传播的影响。
Environ Res. 2023 Jul 1;228:115907. doi: 10.1016/j.envres.2023.115907. Epub 2023 Apr 18.
2
Exploring the linkage between seasonality of environmental factors and COVID-19 waves in Madrid, Spain.探索西班牙马德里环境因素的季节性与新冠疫情波之间的联系。
Process Saf Environ Prot. 2021 Aug;152:583-600. doi: 10.1016/j.psep.2021.06.043. Epub 2021 Jun 30.
3
Cumulative effects of air pollution and climate drivers on COVID-19 multiwaves in Bucharest, Romania.

本文引用的文献

1
Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.COVID-19 人体挑战研究的伦理可接受性的关键标准:世卫组织工作组的报告。
Vaccine. 2021 Jan 22;39(4):633-640. doi: 10.1016/j.vaccine.2020.10.075. Epub 2020 Oct 28.
2
Stability of SARS-CoV-2 in different environmental conditions.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在不同环境条件下的稳定性
Lancet Microbe. 2020 May;1(1):e10. doi: 10.1016/S2666-5247(20)30003-3. Epub 2020 Apr 2.
3
Performance Assessment of SARS-CoV-2 PCR Assays Developed by WHO Referral Laboratories.
空气污染和气候驱动因素对罗马尼亚布加勒斯特新冠疫情多波传播的累积影响。
Process Saf Environ Prot. 2022 Oct;166:368-383. doi: 10.1016/j.psep.2022.08.042. Epub 2022 Aug 20.
4
Impacts of exposure to air pollution, radon and climate drivers on the COVID-19 pandemic in Bucharest, Romania: A time series study.罗马尼亚布加勒斯特空气污染、氡气和气候驱动因素对 COVID-19 大流行的影响:一项时间序列研究。
Environ Res. 2022 Sep;212(Pt D):113437. doi: 10.1016/j.envres.2022.113437. Epub 2022 May 18.
5
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2.人血管紧张素转化酶 2 与奥密克戎和德尔塔 SARS-CoV-2 刺突 RBD 的受体结合和复合物结构。
Cell. 2022 Feb 17;185(4):630-640.e10. doi: 10.1016/j.cell.2022.01.001. Epub 2022 Jan 6.
6
Emerging SARS-CoV-2 Variants of Concern (VOCs): An Impending Global Crisis.新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)关注变体(VOCs):一场迫在眉睫的全球危机。
Biomedicines. 2021 Sep 23;9(10):1303. doi: 10.3390/biomedicines9101303.
7
Assessing the impact of air pollution and climate seasonality on COVID-19 multiwaves in Madrid, Spain.评估空气污染和气候季节性对西班牙马德里 COVID-19 多波次传播的影响。
Environ Res. 2022 Jan;203:111849. doi: 10.1016/j.envres.2021.111849. Epub 2021 Aug 6.
8
Clinical characteristics of patients infected with SARS-CoV-2 in North Wollo Zone, North-East Ethiopia.埃塞俄比亚东北部北沃洛州感染新冠病毒患者的临床特征。
Pan Afr Med J. 2021 Feb 25;38:217. doi: 10.11604/pamj.2021.38.217.27859. eCollection 2021.
9
Molecular scaffolds from mother nature as possible lead compounds in drug design and discovery against coronaviruses: A landscape analysis of published literature and molecular docking studies.从大自然母亲中寻找分子支架作为冠状病毒药物设计和发现的潜在先导化合物:已发表文献和分子对接研究的分析。
Microb Pathog. 2021 Aug;157:104933. doi: 10.1016/j.micpath.2021.104933. Epub 2021 May 11.
10
Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.疫苗相关增强疾病:免疫安全性数据的病例定义和数据收集、分析及呈现指南。
Vaccine. 2021 May 21;39(22):3053-3066. doi: 10.1016/j.vaccine.2021.01.055. Epub 2021 Feb 23.
世界卫生组织指定实验室研发的新型冠状病毒聚合酶链式反应检测方法的性能评估
J Clin Med. 2020 Jun 16;9(6):1871. doi: 10.3390/jcm9061871.
4
Immunology of COVID-19: Current State of the Science.COVID-19 的免疫学:科学现状。
Immunity. 2020 Jun 16;52(6):910-941. doi: 10.1016/j.immuni.2020.05.002. Epub 2020 May 6.
5
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.新型冠状病毒肺炎的肺血管内皮细胞炎症、血栓形成和血管生成。
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
6
The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.体液免疫反应在感染 SARS-CoV-2 后的动态变化和再次感染的可能性。
J Gen Virol. 2020 Aug;101(8):791-797. doi: 10.1099/jgv.0.001439.
7
Estimating the burden of SARS-CoV-2 in France.估算法国 SARS-CoV-2 的负担。
Science. 2020 Jul 10;369(6500):208-211. doi: 10.1126/science.abc3517. Epub 2020 May 13.
8
SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults.BCG 疫苗接种和未接种的年轻成年人中的 SARS-CoV-2 比率。
JAMA. 2020 Jun 9;323(22):2340-2341. doi: 10.1001/jama.2020.8189.
9
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.COVID-19 患者的病理性炎症:单核细胞和巨噬细胞的关键作用。
Nat Rev Immunol. 2020 Jun;20(6):355-362. doi: 10.1038/s41577-020-0331-4. Epub 2020 May 6.
10
Type I IFN immunoprofiling in COVID-19 patients.新冠病毒感染患者的I型干扰素免疫谱分析
J Allergy Clin Immunol. 2020 Jul;146(1):206-208.e2. doi: 10.1016/j.jaci.2020.04.029. Epub 2020 Apr 29.